Expanded Gram-Negative Activity of Marinopyrrole A

Area of Science:

• Microbiology
• Medicinal Chemistry
• Infectious Diseases

Background:

• Antimicrobial resistance is a growing global health concern, necessitating novel therapeutic agents.
• Marinopyrrole A is a known drug-like small molecule with demonstrated in vitro activity against Gram-positive bacteria.
• The potential for marinopyrrole A against a broader spectrum of microbes, particularly Gram-negative bacteria, was unexplored.

Purpose of the Study:

• To investigate the efficacy of marinopyrrole A against a wider range of bacterial pathogens.
• To identify specific Gram-negative bacterial species susceptible to marinopyrrole A.
• To elucidate the mechanism underlying marinopyrrole A's activity against Gram-negative bacteria.

Main Methods:

• Screening marinopyrrole A against diverse bacterial strains, including Gram-negative species.
• Correlating bacterial susceptibility with the presence or absence of lipopolysaccharide (LPS).
• Evaluating the synergistic effect of LpxC enzyme inhibitors with marinopyrrole A on resistant strains.

Main Results:

• Marinopyrrole A demonstrated selective efficacy against *Neisseria*, *Moraxella*, and *Campylobacter* species.
• Susceptibility to marinopyrrole A in these Gram-negative bacteria correlated with the absence of canonical LPS.
• Inhibition of LPS synthesis via LpxC pathway molecules enhanced the susceptibility of resistant Gram-negative bacteria to marinopyrrole A.

Conclusions:

• Marinopyrrole A exhibits broader efficacy against Gram-negative bacteria than previously recognized.
• The absence of LPS is a key factor in marinopyrrole A's activity against certain Gram-negative bacteria.
• This study highlights marinopyrrole A's potential as a therapeutic agent against priority pathogens like *N. gonorrhoeae*.